On ECHEMI
Home > Drugs > Doxazosin mesylate Registered Holders
Doxazosin mesylate structure

Doxazosin mesylate structure

Doxazosin mesylate

Doxazosin mesylate(UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.Target: α1-adrenergic receptorDoxazosin (mesylate) is the mesylate salt form of doxazosin, which is a long-lasting inhibitor of α1-adrenoceptors that is widely used to treat benign prostatic hyperplasia and lower urinary tract symptoms [1]. doxazosin may have a direct inhibitory effect on cholesterol synthesis independent of the LDL receptor. The inhibition of choles

Find 34 Related Holders

MIDAS PHARMA GMBH
European Union European Union

API Registration Country

API Active
APITORIA PHARMA PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
NIFTY LABS PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
NOSCH LABS PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
MEDICHEM,S.A.
Japan Japan

API Registration Country

API Active
STANDARD CHEM AND PHARM CO LTD
United States United States

API Registration Country

API Inactive
PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
United States United States

API Registration Country

API Inactive
CILAG AG
United States United States

API Registration Country

API Inactive
WOCKHARDT LTD
Brazil Brazil

API Registration Country

API Inactive
  • Country:

    Brazil Brazil
  • Address:

    WOCKHARDT TOWERS, BANDRA KURLA COMPLEX, EXTERIOR - EX
  • Email:

MEDICHEM SA
Spain Spain

API Registration Country

API Inactive
  • Country:

    Spain Spain
  • Address:

    FRUCTUOS GELABERT 6-8, BARCELONA, SANT JOAN DESPI
  • Email:

Recommended Suppliers of Doxazosin mesylate
View 113 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.